Type 2 Diabetes Flashcards
What causes type 1 diabetes?
A culmination of lymphocytic infiltration and destruction of insulin-secreting beta cells of the islets of Langerhans in the pancreas. As beta-cell mass declines, insulin secretion decreases until the available insulin is insufficient to maintain normal blood glucose levels.
What causes type 2 diabates?
When cells in the muscle, fat, and liver become resistant to insulin, causing them to no longer take in enough sugar. The pancreas then can’t produce enough insulin to keep blood sugar levels within a healthy range.
What are some common symptoms of type 2 diabetes?
Polydipsia - thirst
Polyuria – frequent urination
Blurred vision
Unexplained weight loss
Recurrent infections
Tiredness
Acanthosis nigricans – skin condition caused by dark pigmentation of skin folds. Suggests insulin resistance.
What is persistent hyperglycaemia defined as?
HbA1c 48mmol/L (6.5%) or more
Fasting plasma glucose 7mmol/L or more
Randome plasma glucose 11.1mmol/L or more in the presence of symptoms of diabetes.
In which groups should HbA1c not be used to determine persistent hyperglycaemia?
<18
Pregnant women
2 months postpartum
<2 months diabetes symptoms
Medication which cause hyperglycaemia e.g., longterm corticosteroids.
Acute pancreatic damage
End-stage renal damahe
HIV
Why should diabetes not be diagnosed based on a one-off blood test?
Hyperglycaemia can be due to trauma, infection, stress
What are risk factors for type 2 diabetes?
Obesity and inactivity
Family history
Ethnicity - Asian, African, Afro-Caribbean
History of gestational diabetes
Diet - low fibre or high glycaemic index foods
Drug treatments - statins, corticosteroids
PCOS
Metabolic syndrome
Low birth weight
What is the target HbA1c level if T2D managed by lifestyle changes alone?
48mmol/mol (6.5%)
What is the target HbA1c level if T2D managed by lifestyle changes with a single drug not associated with hypoglycaemia?
48mmol/mol (6.5%)
What is the target HbA1c level if T2D managed by drug treatment associated with hypoglycaemia?
53mmol/mol (7%)
When should HbA1c levels be measured?
3-6 monthly intervals until stable, then every 6 months.
What lifestyle advice should be given to someone with type 2 diabetes?
Join group education programme such as DESMOND.
Eat high fibre, low-glycaemic index sources of carbohydrates such as fruit, vegetables, wholegrains, and pulses.
Eat low-fat dairy products.
Oily fish.
Reduce foods containing high-saturated fats, sugar, and salt.
Minimise time spent being sedentary.
Advise regular exercise to lower blood glucose levels, improve CVD risk, and reduce excess weight.
If drinking, eat a snack containing carbohydrates before and after drinking as alcohol can exacerbate and prolong effects of antidiabetic drugs leading to hypoglycaemia.
How should T2D be treated?
- Metformin
- SGLT2 inhibitor – if have or at risk of CH or CVD. Can use SGLT2 inhibitor alone if metformin contraindicated or not tolerated.
- DPP4 inhibitor OR pioglitazone OR sulfonylurea OR SGLT2 inhbior (if not using already) – dual therapy if monotherapy insufficient.
- insulin therapy OR DPP4 inhibitor OR pioglitazone OR sulfonylurea OR SGLT2 inhbior (if not using already) – triple therapy if dual therapy insufficient.
- If triple therapy ineffective, not tolerated, or contraindicated, consider switching one drug to a GLP-1 receptor antagonist if their BMI is 35kg/m2 or higher, or if it is lower an insulin therapy would have implications, or if obesity would benefit an obesity-related comorbidity.
How does metformin work?
Metformin opposes glucagon and activates AMPK which inhibits hepatic gluconeogenesis (production of glucose from precursors such as glycerol, lactate, pyruvate etc)
How should metformin be initiated?
Gradually increased weekly (usually by 500mg) over several weeks to minimise the risk of adverse effects and to identify the minimum dose for adequate glycaemic control. If there are intolerable GI adverse effects, consider a trial on MR metformin.
What are some adverse effects of metformin?
GI – nausea, flatulence, abdominal pain, diarrhoea, appetite decreased.
Lactic acidosis – lactic acid build up in the blood stream which can cause GI discomfort, exhaustion, muscle cramps, respiratory compensation/dyspnoea, and hypothermia. Discontinue immediately. Higher risk in patients with heart failure.
Reduced vitamin B12 levels at high doses – breathlessness, fatigue, light-headedness. Monitor levels and supplement, continue metformin as long as it is tolerated.
Skin reactions such as erythema, pruritis, and urticaria.
What monitoring does metformin require?
Renal function – baseline and annually (at least) or 6 monthly if risk factors.
Do not start if eGFR <30ml/min/1.73m2.
If at review eGFR <45ml/min/1.73m2, review dose.
Stop treatment if eGFR <30ml/min/1.73m2 or patient at risk of tissue hypoxia or sudden deterioration in renal function.
B12 (folate) serum levels
Test levels if deficiency suspected.
Consider periodic monitoring in patients with risk factors.
What are some common drug interactions of metformin?
Alcohol – increased risk of lactic acidosis.
Beta-blockers – warning signs of hypoglycaemia (such as tremor) may be masked during concurrent treatment.
Ketotifen – platelet count may be depressed.
Topiramate – plasma concentrations of metformin increased.
Hypoglycaemic effects may be enhanced by other anti-diabetic drugs, ACE inhibitors, MAOIs, anabolic steroids.
Hypoglycaemic effects may be prevented by corticosteroids, diuretics, oestrogen/progesterone.
When should an SGLT-2 inhibtor be prescribed in type 2 diabetes?
In combination with metformin first line if at risk of CHF or CVD
Alone if metformin contraindicated.
How should SGLT-2 inhibitors be prescribed with metformin?
Sequentially - start metformin, then when tolerability confirmed, initate SGLT-2 inhibitor
How do SGLT-2 inhibitors work?
Inhibit sodium-glucose cotransport-2 to reduce renal tubule glucose reabsorption, producing a reduction in blood glucose without stimulating insulin release.
They also have a mild diuretic effect and decrease sodium, which results in sodium homeostasis and a decrease in plasma volume which decreases BP and improves cardiac blood flow, which plays a role in treating heart failure.
Name 3 SGLT-2 inhibitors.
Dapagliflozin
Canagliflozin
Empagliflozin
What are some common side effects of SGLT-2 inhibitors?
Constipation
Nausea
Dyslipidaemia
Hypotension
Vulvovaginitis, UTO, urosepsis.
What are some serious side effects of SGLT-2 inhibitors?
Renal impairment.
Fournier’s gangrene – a rare but life-threatening necrotizing fasciitis of the genitals and perineum which presents as severe pain or tenderness, erythema, and swelling in genital area, with fever and malaise. Stop SGLT-2 inhibitor immediately and seek medical attention.
Diabetic ketoacidosis – occurs when the body doesn’t have enough insulin to allow blood sugar into the cells to use as energy. Instead, liver breaks down fat for fuel which produces ketones at a rapid rate which can build up dangerous levels in the body. This can lead to thirst, polyuria, dyspnoea, stomach pain, nausea, and fruit smelling breath.
What monitoring do SGLT-2 inhibitors require?
Renal function – do not initiate treatment if eGFR < 60ml/min/1.73m2. However, dapagliflozin is licensed for use in CKD and can improve renal function but should not be used if eGFR <15ml/min/1.73m2.
Monitor for symptoms of DKA – stop immediately and seek medical attention.
What are some common drug interactions of SGLT-2 inhibitors?
Thiazide and loop diuretics – additive effects which can increase risk of dehydration and hypotension.
Insulin and other antidiabetic drugs – hypoglycaemia.
Enzyme-inducers such as St John’s wort, rifampicin, phenytoin, carbamazepine.
Lithium – increased renal lithium excretion and decreased blood levels
Name 2 SPP4 inhibitors?
Saxaglipin
Alogliptin
How do DPP4 inhibitors work?
Bind to dipeptidyl peptidase-4 and prevent it from destroying incretin, a hormone involved in glucose homeostasis which stimulates insulin production and inhibits glucose production when required.
What monitoring do DPP4 inhibitors require?
LFTs - baseline, every 3 months for 1 year, periodically thereafter. Avoid in heoatic impairment.
Renal function - baseline, annually. Use with caution in renal impairment.
What are some adverse effects of DPP4 inhibitors?
GI – constipation, vomiting, nausea, reflux, dyspepsia.
Dizziness and tremor
Pruritis, urticaria, angioedema, rash.
Pancreatitis (acute) – short-term inflammation of the pancreas. Seek urgent medical attention and stop treatment if patient develops jaundice or other signs of liver dysfunction such as nausea, diarrhoea, indigestion, fever, tenderness of abdomen, and dark urine.
Hepatic – hepatitis and hepatic failure – RARE.
What are some common drug interactions of DPP4 inhibitors?
Beta-blockers – warning signs of hypoglycaemia (e.g., tremor) may be masked.
ACE inhibitors – increased risk of angioedema with vildagliptin.
Digoxin – sitagliptin increases plasma concentrations of digoxin.
Rifampicin – decreases linagliptin effects.
Hypoglycaemic effects may be enhanced by other anti-diabetic drugs, alcohol, MAOIs, anabolic steroids.
Hypoglycaemic effects may be prevented by corticosteroids, diuretics, oestrogen/progesterone.
What is pioglitazone?
A synthetic ligand for PPARs which alter the transcription of genes influencing carbohydrate and lipid metabolism, which results in reduced insulin resistance and gluconeogenesis in the liver.
Before treatment with pioglitazone, what do patients need to undergo?
LFTs – If ALT is >2.5x the upper limit of normal do not start. Monitor LFTs regardless periodically based on clinical judgement.
Risk of heart failure – contraindicated. Monitor for signs and symptoms of heart failure throughout treatment such as weight gain or oedema. Stop treatment if decline in cardiac function seen.
Risk of bone fracture – can cause this.
Risk of bladder cancer - risk factors include age, smoking history, certain drugs, and pelvic radiation therapy. Do not start in individuals with bladder cancer. Risk of bladder cancer development. Seek urgent medical attention if symptoms develop such as unexplained weight/appetite loss, dysuria, DVT, UTI.
Assess the safety and efficacy of pioglitazone 3-6 months after treatment is initiated and regularly thereafter. Stop treatment where response is not adequate.
What are some adverse effects of pioglitazone?
Pee cancer (bladder cancer
Insomnia
Optic - visual impairment
Gain weight
Liver impairment
Increased risk of infection and bone fractures
PIOGLI
What are some common drug interactions with pioglitazone?
Beta-blockers – warning signs of hypoglycaemia (e.g., tremor) may be masked.
NSAIDs – peripheral oedema and cardiac failure. Stop treatment if decline in cardiac function seen.
Liver-enzyme inducing drugs may reduce plasma concentration of pioglitazone and may warrant dose change. These include: rifampicin, phenytoin, carbamazepine, St John’s wort.
Hypoglycaemic effects may be enhanced by other anti-diabetic drugs, alcohol, MAOIs, anabolic steroids.
Hypoglycaemic effects may be prevented by corticosteroids, diuretics, oestrogen/progesterone
Name 4 sulfonylureas.
Gliclazide
Glimepiride
Glipizide
Tolbutamide
How do sulfonylureas work?
Bind to sulfonylurea receptors to close ATP-sensitive K-channels in the beta-cell plasma membrane to stimulate insulin release.
What monitoring do sulfonylureas require?
Blood glucose at start of treatment to monitor for hypoglycaemia
Renal and hepatic function - baseline. Continuous monitoring in moderate impairment. Avoid in severe.
What are some adverse effects of sulfonylureas?
GI – abdominal pain, nausea, vomiting, diarrhoea, and constipation.
Hepatic impairment.
Skin – rash, pruritis, urticaria, photosensitivity.
Blood – leucopenia, thrombocytopenia, anaemia.
Hypoglycaemia.
What are some common drug interactions of sulfonylureas?
Beta-blockers – warning signs of hypoglycaemia (e.g., tremor) may be masked.
Colesevelam – decreased sulfonylurea absorption – separate by 4 hours.
Fluconazole, Fluvastatin – increased sulfonylurea plasma concentration.
Phenytoin – increased phenytoin plasma concentration.
Hypoglycaemic effects may be enhanced by other anti-diabetic drugs, alcohol, MAOIs, anabolic steroids, NSAIDs, ACE inhibitors, some antibiotics.
Hypoglycaemic effects may be prevented by corticosteroids, diuretics, oestrogen/progesterone, and pehnothiazines.
How do GLP-1 agonists work?
Bind to glucagon-like peptide-1 receptor on islet beta-cells and gamma cells to stimulate insulin and somatostain (SMS) secretion, respectively. Insulin works to promote glycogenesis and inhibit gluconeogenesis, while SMS inhibits glucagon secretion from islet cells.
How are GLP-1 receptor agonists administered?
Once weekly via SC injections.
Who shoudln’t be prescribed GLP-1 receptor agonists?
Patients with:
Ketoacidosis
Pancreatitis
Renal impairment
Severe hepatic impairment
Severe GI disease